PyroMark Q24 MDx

For IVD-validated mutation and methylation analysis using Pyrosequencing technology

Compliant with EU IVD Directive 98/79/EC
Reliable quantification of allele representation and methylation status
Sequence information enables discovery of rare mutations
More than one assay can be completed in a single run
1–24 samples can be analyzed in as little as 15 minutes

The PyroMark Q24 MDx uses proven Pyrosequencing technology for real-time, sequence-based detection and quantification for in vitro diagnostic use in Europe. This innovative platform is highly suited for genotyping mutations, evaluating disease-related DNA methylation patterns, validating biomarkers, and other diagnostic-related assays.

Specifications

Specifications

Features	Specifications
Altitude	Up to 2000 m (6500 ft)
Applications	Methylation analysis, allele quantification, genotyping, sequence analysis
CE/FDA/IVD compatible	In Europe
Chemical resistance	pH 4 to pH 9, common detergents, 0.5 M sodium hydroxide, ethanol
Connections	One USB port (2.0)
Humidity	Relative humidity of 20–90% (noncondensing)
Instrument dimensions	420 x 390 x 525 mm (16.5 x 15.4 x 20.7 in.)
Kits designed for this instrument	IVD-labeled therascreen Kits
Operating temperature	15–32°C (59–90°F)
Overvoltage category	II
Place of operation	For indoor use only
Pollution level	2
Power	100–240 V AC, 47–63 Hz, 1.1–0.45 A (grounded). From external power supply to instrument: 12 VDC and 24 VDC nominal
Process temperature	28°C (82.4°F) ± 1°C
Process time	Depends on the number of nucleotide dispensations (20 dispensations take 24 minutes)
Samples per run (throughput)	1–24
Software	PyroMark Q24 MDx Software 2.0
Technology	Pyrosequencing
Weight	27.5 kg (60.6 lb)